Author:
Cortada-Garcia Joan,Daly Rónán,Arnold S. Alison,Burgess Karl
Abstract
AbstractMetabolomics is a powerful tool for the identification of genetic targets for bioprocess optimisation. However, in most cases, only the biosynthetic pathway directed to product formation is analysed, limiting the identification of these targets. Some studies have used untargeted metabolomics, allowing a more unbiased approach, but data interpretation using multivariate analysis is usually not straightforward and requires time and effort. Here we show, for the first time, the application of metabolic pathway enrichment analysis using untargeted and targeted metabolomics data to identify genetic targets for bioprocess improvement in a more streamlined way. The analysis of an Escherichia coli succinate production bioprocess with this methodology revealed three significantly modulated pathways during the product formation phase: the pentose phosphate pathway, pantothenate and CoA biosynthesis and ascorbate and aldarate metabolism. From these, the two former pathways are consistent with previous efforts to improve succinate production in Escherichia coli. Furthermore, to the best of our knowledge, ascorbate and aldarate metabolism is a newly identified target that has so far never been explored for improving succinate production in this microorganism. This methodology therefore represents a powerful tool for the streamlined identification of strain engineering targets that can accelerate bioprocess optimisation.
Funder
Biotechnology and Biological Sciences Research Council
Industrial Biotechnology Innovation Centre
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Fleming, A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzæ. Br. J. Exp. Pathol. 10, 236 (1929).
2. Demain, A. L., Vandamme, E. J., Collins, J. & Buchholz, K. History of industrial biotechnology. In Industrial Biotechnology : Microorganisms (eds Wittmann, C. & Liao, J. C.) 3–84 (Wiley, 2016).
3. Ro, D. K. et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440(7086), 940–943 (2006).
4. Paddon, C. J. et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496, 528–532 (2013).
5. Adamczyk, P. A. & Reed, J. L. Escherichia coli as a model organism for systems metabolic engineering. Curr. Opin. Syst. Biol. 6, 80–88 (2017).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献